Home > Boards > US Listed > Medical - Equipment >

Neovasc, Inc. (NVCN)

NVCN RSS Feed
Add NVCN Price Alert      Hide Sticky   Hide Intro
Moderator: lister
Search This Board: 
Last Post: 5/24/2019 12:54:33 PM - Followers: 215 - Board type: Free - Posts Today: 0


Trading for
$0.061 as of Thurs. March 29th, 2018, well under two recent Price Targets of $2.00 and $0.50.
Increased chatter amongst investors of a Partnership or Buyout, see below. 


Latest Analyst Ratings:

March 29th, 2018 3:07 AM EDT
Neovasc Inc. PT updated to $2.00 at Leerink Partners, states that 'Tiara Clinical Trials Continue to Progress' Maintains 'Outperform' Rating.
https://www.streetinsider.com/Analyst+PT+Change/Neovasc+%28NVCN%29+PT+Lowered+to+%242+at+Leerink+Partners%3B+Tiara+Clinical+Trials+Continue+to+Progress/13997143.html

March 29th, 2018 
Canaccord Genuity Updates Neovasc Inc (US) (NVCN) Price Target to $0.50 and has a "Buy" rating.
https://registrarjournal.com/2018/03/29/canaccord-genuity-lowers-neovasc-inc-us-nvcn-price-target-to-0-50.html


Latest Earnings Report - March 28th, 2018
https://seekingalpha.com/article/4159758-neovascs-nvcn-ceo-fred-colen-q4-2017-results-earnings-call-transcript
EPS of $-0.28 misses by $-0.02 
Revenue of $5.39M (- 43.3% Y/Y) beats by $1.29M

Trader's takeaway from the latest Earnings Report: (Updated on April 1st, 2018)
1. No R/S mentioned, 2. Tiara Prescreen implementation in Europe soon (as early as this week), 3. Updates on Tiara / Reducer enrollments shown to have been very successful and increasing in size, 4. Cash to last through Q3 2018, 5. Revenues were down/but so were expenses.

Also on the conference call, they reported that the $112 M lawsuit has been fully paid and settled. Neovasc said that “there are no other monetary damages arising from the award,” and announced that it will remain the joint inventor of its ‘964 patent related to its Tiara transcatheter mitral valve replacement device. Neovasc will share the patent along with 2 employees of CardiAQ Valve, with both parties “having freedom to use the patent without an obligation to pay royalties to the other", according to a press release. Source: NeoVasc shares surge 45% on affirmed Tiara patent case decision against Edwards.  https://www.massdevice.com/neovasc-shares-surge-45-affirmed-tiara-patent-case-decision-edwards/

Possible Partnership in the works?
This was taken from the latest Earnings Conference call on March 28th, 2018 (link to entire transcript provided above, courtesy of SeekingAlpha.com)
Newly acquired CEO/President Fred Colen hints at being open to a partnership.  Have a look at what he says:
Possible partnership?

Possible Buy Out in the works? 
Check out newly acquired CEO Fred Colen's bio below (spoiler alert: he worked with $BSX for 8 years as CTO) and see how this all ties together. 

Don't Be Surprised if Boston Scientific (BSX) Buys Neovasc (NVCN)- JMP  



MARCH 30, 2018 Article:
http://www.editiontruth.com/heart-valve-devices-market-projected-grow-us-16-2-bn-end-2025/



Neovasc has a unique opportunity to take a share of that US$16.2 Billion with this patent along with many other patents that they own.
Patent # 
8,579,964  (Link to USPTO - UNITED STATES PATENT AND TRADEMARK OFFICE)
SOURCE:  http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,579,964.PN.&OS=PN/8,579,964&RS=PN/8,579,964

VERY IN DEPTH DD HERE - ANOTHER MUST READ HERE 
Neovasc's Tiara and other TMVR devices
https://docs.google.com/document/d/1OvI4lcwVL_NbcH9SIveG-sWiSWfTfRUZxlxEcUV_5RA/edit
______________________________________________________________________________________________________________________
______________________________________________________________________________________________________________________
{{{{{MAJOR UPDATE:ACQUISITION ALERT COLLABORATION WITH BOSTON SCIENTIFIC :Nasdaq"BSX" TAKING 15% OWNERSHIP STAKE IN: Nasdaq"NVCN" AND 
US$75 MILLION AGREEMENT 12/02/16}}}}
                                                        

Neovasc and Boston Scientific Reach US$75 Million Agreement 
12/2/2016 7:00:00 AM - PR Newswire 

 
Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities 
12/2/2016 7:00:00 AM - PR Newswire 

NVCN + BSX = 15% stake = +350% for stock
                                                                                                       

 

Fred Colen - President and CEO
LOOK AT WHO WAS BROUGHT INTO AS CEO / PRESIDENT ON JANUARY 22nd 2018 AND THE CONNECTIONS WITH BOSTON SCIENTIFIC ($BSX)!!! 

Neovasc Inc. (Nasdaq: NVCN), a front-runner in minimally invasive transcatheter mitral valve technologies today announced that its board of directors (the "Board") has appointed Fred A. Colen as president and chief executive officer effective immediately. This leadership transition is a key element of the Company's strategy to support plans for the commercialization of its new-to-market Reducer™ ("Reducer") product in Europe and the advancement of its Tiara™ ("Tiara") mitral valve clinical program. Alexei Marko, Neovasc's outgoing CEO, will maintain his role as a Director on the Neovasc Board of Directors and continue to serve as an advisor to the Company.  

"After ten years building Neovasc, I am convinced that now is the time for new leadership to take the Company to the next level. I am especially pleased that an industry leader of Fred Colen's caliber has accepted this opportunity," said Alexei Marko, outgoing CEO of Neovasc. "I look forward to my continued involvement as a board member." 

Fred Colen has contributed to many significant turnarounds in his career, including the post-acquisition Guidant Company, which became the CRM division of Boston Scientific, a firm with which he held progressively senior executive roles over 11 years, including Chief Technology Officer from 2001-2008 and Member of the Executive Committee from 2001-2010. During his tenure at Boston Scientific, Mr. Colen is credited with numerous successes. As President of the company's Cardiac Rhythm Management (CRM) Group his team regained trust and confidence in the division's implantable pacemakers, leads, defibrillators and re-synchronization devices, increasing annual product revenue growth by over 10% in a flat US market and growing global divisional operating income from below 10% to 25% of sales, exceeding the planned annual free cash flow goals. As Chief Technology Officer, he led the development and global commercial launch for the Company's first- and second-generation implantable drug-eluting coronary stents (the Taxus Express and Taxus Liberte), leading to global market leadership with incremental revenues of US$2 billion annually. The Taxus Express market introduction is viewed as one of the most successful launches ever in the medical device industry. 


Also note:
$BSX Boston Scientific laid off 300 employees just recently on March 27th, 2018
, perhaps to make room for the takeover of $NVCN ?? Who knows?? They already own 15% of NVCN.
source: https://www.massdevice.com/boston-scientific-lays-off-nearly-300-from-valencia-neuromod-facilities/ 

          
                                                                                          


                                                                      About Neovasc                                                                        

                                                     Neovasc Inc. is a specialty medical device company that develops, manufactures,
                                                     and markets products for the rapidly growing cardiovascular marketplace.

                                                                        Our products include the Tiara™ technology in development for the transcatheter
                                                                        treatment of mitral valve disease, the Neovasc Reducer™ for the treatment of
                                                                        refractory angina.

                                                                         A Canadian Biotech company, headquartered in Vancouver, B.C. Canada, we are a
                                                                         publicly traded company, listed on NASDAQ: (NVCN) and the Toronto Stock
                                                                         Exchange TSX: (NVC) 


 

PRODUCTS

Tiara
Reducer

                                                    BUYOUT POTENTIAL                                        
              ------------------>>>>>>>>>>>>>Recent deals involving mitral valve companies<<<<<<<<<<<<<<--------------
"Great info and a MUST READ on the demand and for acquisitions for these type of companies here from last year this month now that remainder or any legal issues are getting ironed out through the final appeals days now , EVEN SHOWS THE $$ VALUES OF THE BOUGHT COMPANIES TOO:"
http://seekingalpha.com/article/3562756-boston-arrives-late-mitral-valve-party


""""UPDATE : NO INJUNCTION FOR TIARA DEVICE , CAN NOW MOVE FORWARD THUS MAKING IT MORE ATTRACTIVE FOR FUTURE BUYOUT"""""



Concensus Recommendation courtesy of NASDAQ.com 
Updated: April 1st, 2018:   STRONG BUY.
Source: https://www.nasdaq.com/symbol/nvcn/analyst-research


STRONG BUY                                  
NVCN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVCN News: Report of Foreign Issuer (6-k) 05/23/2019 09:41:20 AM
NVCN News: New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris 05/23/2019 09:17:00 AM
NVCN News: New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris 05/23/2019 09:17:00 AM
NVCN News: New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris 05/23/2019 09:17:00 AM
NVCN News: New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris 05/23/2019 09:17:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#11598   48 seems to be bottom mrdeals 05/24/19 12:54:33 PM
#11597   unfortunately, in the hands of day traders and LutherTiggs 05/24/19 09:59:07 AM
#11596   Yup, sell the news on this thing as Snug Harbour 05/24/19 08:58:12 AM
#11595   I am out as well. Was lucky and powerbattles 05/23/19 05:40:11 PM
#11594   Agreed. Hey we made money and that is cjstocksup 05/23/19 04:57:39 PM
#11593   * * $NVCN Video Chart 05-23-2019 * * ClayTrader 05/23/19 04:46:14 PM
#11592   This is crazy chit. powerbattles 05/23/19 03:56:37 PM
#11591   I think you are right. powerbattles 05/23/19 03:48:58 PM
#11590   Those were selling but stop losses made it cjstocksup 05/23/19 03:44:38 PM
#11589   That 11 million dollar notes hit it hard powerbattles 05/23/19 03:10:27 PM
#11588   I think they will run it hard into cjstocksup 05/23/19 02:44:28 PM
#11587   TOMMOROW MORE GREEN karimo 05/23/19 02:27:22 PM
#11586   I bought last night and sold at premarket powerbattles 05/23/19 02:21:17 PM
#11585   Too bad the NVCN news hit on such cjstocksup 05/23/19 02:14:00 PM
#11584   YUP! Trying to flip it all day long. powerbattles 05/23/19 02:10:02 PM
#11583   Hope you have been having as much fun cjstocksup 05/23/19 02:07:40 PM
#11582   SS was a lot different then I’m sure.... Cowman45 05/23/19 01:48:51 PM
#11581   OMG! NVCN was trade $1050 in 2015 wowwwwwwww. powerbattles 05/23/19 01:26:18 PM
#11580   Hopefully the toxic idiot allow to let it powerbattles 05/23/19 01:04:35 PM
#11579   Got a good load 0,64 but stop is in europtiger 05/23/19 11:51:35 AM
#11578   Today a lot of hands changed. I believe Jonas83 05/23/19 11:37:53 AM
#11577   STUPID PUMP AND DUMP HERE. THEY NEED TO powerbattles 05/23/19 11:13:39 AM
#11576   Awesome news today. powerbattles 05/23/19 10:54:21 AM
#11575   News: $NVCN New Tiara and Reducer Data Presented whytestocks 05/23/19 09:50:38 AM
#11574   .65-.77 and DONE ? JJGl 05/23/19 09:37:11 AM
#11572   Precisely as you predicted Disquisition 05/23/19 08:34:13 AM
#11571   Looking good big boys and wallets coming out zeusgodmd 05/23/19 07:53:36 AM
#11570   Who was arguing with me about this? 777 05/23/19 06:15:29 AM
#11569   https://www.internationaljournalofcardiology.com/article/S0167-5273(18)37354-6/f hmuney 05/23/19 03:18:22 AM
#11568   https://www.sciencedirect.com/science/article/pii/S0167527318373546 hmuney 05/23/19 03:15:36 AM
#11567   I've seen this before on a stock. Huge Wantcash 05/22/19 09:03:53 PM
#11566   UP TO .69 in AFTER HOURS HEAVY TRADING LutherTiggs 05/22/19 06:46:25 PM
#11565   Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy LutherTiggs 05/22/19 05:40:01 PM
#11564   NEWS BELOW. LutherTiggs 05/22/19 05:38:30 PM
#11563   price up after hours. News? LutherTiggs 05/22/19 05:34:18 PM
#11562   With this amount of shares $1.0 is realistic lister 05/22/19 12:47:44 PM
#11561   Volume spike, hoping for news of PMA submission. swing4thefences 05/21/19 11:25:18 AM
#11560   Does it say much that the company sold Don 05/14/19 10:06:30 PM
#11559   Hi Clay, thx for the analysis. I have Willie2002 05/14/19 08:32:58 PM
#11558   * * $NVCN Video Chart 05-09-2019 * * ClayTrader 05/09/19 05:07:09 PM
#11557   News: $NVCN Neovasc Announces First Quarter 2019 Financial Results whytestocks 05/09/19 04:40:40 PM
#11556   ER should be great, heating up during lunch hour. swing4thefences 05/09/19 12:40:06 PM
#11555   Check out GDSI. Been watching since yesterday. 777 05/09/19 11:36:06 AM
#11554   You’re 100% right. 777 05/09/19 11:35:15 AM
#11553   let us see lister 05/08/19 01:12:48 PM
#11552   tomorrow with the earnings report we should start Diegote10 05/08/19 01:11:39 PM
#11551   no, perhaps something in the air lister 05/08/19 12:55:00 PM
#11550   Some positive action today? LarryT14 05/01/19 08:29:53 AM
#11549   .47 some action. Testing daily high Attila1905 04/24/19 12:07:44 PM
#11548   They tried to pump it to $1 but kragdason 04/22/19 10:59:49 PM
PostSubject